SCHEMBL2015268

SCHEMBL2015268

CN(C(=O)O)C1CCN(c2c(CCN)cc(Cl)c3cccnc23)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.40
NTRK1 P04629 1/20 0.40
FYN P06241 1/20 0.40
RET P07949 1/20 0.40
MET P08581 1/20 0.40
PDGFRB P09619 1/20 0.40
PIM1 P11309 1/20 0.40
FGFR1 P11362 1/20 0.40
PDGFRA P16234 1/20 0.40
LTK P29376 1/20 0.40
MAP2K2 P36507 1/20 0.40
FLT3 P36888 1/20 0.40
MAPK8 P45983 1/20 0.40
MAPK9 P45984 1/20 0.40
CDK8 P49336 1/20 0.40
GSK3B P49841 1/20 0.40
CDK7 P50613 1/20 0.40
CDK9 P50750 1/20 0.40
NEK2 P51955 1/20 0.40
JAK3 P52333 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2014356 0.95 JAK1 (0.39) CHEK1NTRK1FYNRETMET
SCHEMBL2016659 0.95 JAK1 (0.39) CHEK1NTRK1FYNRETMET
SCHEMBL2012926 0.83 SMO (0.48) METAP2NPSR1KMT2AALDH1A1MEN1
SCHEMBL2012673 0.83 NPC1 (0.42) CHEK1NTRK1FYNRETMET
SCHEMBL2015267 0.82 NPC1 (0.42) CHEK1NTRK1FYNRETMET
SCHEMBL2019128 0.82 METAP2 (0.44) METAP2NPSR1KMT2AALDH1A1MEN1
SCHEMBL2017182 0.82 HTT (0.47) METAP2NPSR1KMT2AALDH1A1MEN1
SCHEMBL2018508 0.81 KDM4E (0.43) METAP2NPSR1KMT2AALDH1A1MEN1
SCHEMBL2013467 0.81 SMN1; SMN2 (0.41) METAP2NPSR1KMT2AALDH1A1MEN1
SCHEMBL2011771 0.81 METAP2 (0.41) METAP2NPSR1KMT2AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011075630-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2011-06-23 WO disclosed